Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Digestive Diseases and Sciences|May 3, 2025
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune HepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Hepatology Communications|July 28, 2025
Outcome of hepatic resection for HCC in ideal and non-ideal candidatesLorenzo Lani, Laura Bucci, Valentina Santi, et al.
Alimentary Pharmacology & Therapeutics|January 14, 2026
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter StudyElisa Pinto, Filippo Pelizzaro, Vittorio Simeon, et al.
Oncology Research|April 3, 2026
The Effect of Metformin on Atezolizumab/Bevacizumab Treatment in Patients with Hepatocellular Carcinoma and DiabetesAndrea Dalbeni, Marco Vicardi, Leonardo A Natola, et al.
Liver Cancer|April 22, 2026
Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2025
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World DatabaseAlessandro Loglio, Ivan Gardini, Massimiliano Conforti, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2026
Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinomaPei-Chang Lee, Alessio Cortellini, Bernardo Stefanini, et al.
Hepatology (Baltimore, Md.)|July 19, 2024
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatmentCiro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, et al.
JHEP Reports : Innovation in Hepatology|September 16, 2024
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry studyAlessandro Vitale, Silvia Trapani, Francesco Paolo Russo, et al.
Liver Cancer|October 9, 2025
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse StudyAlessandro Vitale, Jung Sun Kim, Giuseppe Cabibbo, et al.
Pageof 9